Factors associated with seizure severity among children with epilepsy in Northern Nigeria

Idris A Adedeji1, Adamu S Adamu1, Faruk M Bashir1

  • 1Department of Paediatrics, Abubakar Tafawa Balewa University, Bauchi, Nigeria.

Ghana Medical Journal
|August 3, 2022
PubMed

Insights

Neurological co-morbidities in children with epilepsy are linked to increased seizure severity. Identifying these comorbidities can help predict outcomes and guide treatment plans for pediatric epilepsy.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Research
  • Clinical Epidemiology

Background:

  • Epilepsy is a common neurological disorder in children.
  • Seizure severity can be influenced by various factors, including comorbidities.
  • Understanding these influences is crucial for effective management.

Purpose of the Study:

  • To investigate the association between socio-demographic and clinical variables and seizure severity in children with epilepsy.
  • To identify predictors of seizure severity in a pediatric population.

Main Methods:

  • A cross-sectional study was conducted with sixty children and adolescents diagnosed with epilepsy.
  • Data on socio-demographics and neurological comorbidities were collected.
  • Seizure severity was assessed using the National Hospital Seizure Severity Score (SSS).

Main Results:

  • The mean Seizure Severity Score (SSS) was 12.22 ± 4.29.
  • The presence of neurological comorbidities was significantly associated with higher SSS (p=0.019).
  • Neurological comorbidities predicted an increase in SSS by 2.67 units.

Conclusions:

  • Neurological comorbidities are significant predictors of increased seizure severity in children with epilepsy.
  • This finding can aid in prognostication and treatment planning for pediatric epilepsy cases.
  • Further research into managing comorbidities in epilepsy is warranted.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
570
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
268
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
424
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
587
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
830
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
262